CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Laboratoire Franais Du Fractionnement Et Des Biotechnologies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 6, 2023Stable Liquid Fibrinogen3
Aug 2, 2023Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific Antibody1
Jan 12, 2022Use Of An Antibody Directed Against A Membrane Protein1
May 26, 2021New Use Of An Anti-Cd303 Transmembrane Protein Antibody1
Jun 17, 2020Cell Line Overexpressing Human Cd303 Antigen1
Sep 4, 2019Method For Preparing Human Plasma Proteins1
Jul 11, 2018Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs2